Lanton Law Quoted in Pharmacy Times Interview on Drug Pricing Reforms Amid the Repeal of Executive Order 14087 Lanton Law was quoted in the Pharmacy Times Article titled "Reversal of Executive Order (EO) 14087 Raises Questions About Future Drug Pricing Reforms.” We discuss the EO and how pharmacists are impacted. The article can be viewed here. Read More healthcare, FDA, CMS, life sciences, Medicare, pharmacy, pharmaceuticals, pharmacy benefit manager, Pharmacy Times, PhRMARon LantonJanuary 28, 2025Executive Order 14087, drug pricing, Inflation Reduction Act, HHS, FDA, biosimilars, oncology, Medicare, CMS, pharmacy, PhRMA, PBM
